Results 181 to 190 of about 12,580 (199)

Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia

International Immunopharmacology, 2021
Masoud Solaymani-Dodaran, Mostafa Ghanei, Seyed Hassan Saadat   +2 more
exaly  

Favipiravir, an antiviral for COVID-19?

Journal of Antimicrobial Chemotherapy, 2020
Eric A Coomes, Hourmazd Haghbayan
exaly  

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Antiviral Research, 2013
Yousuke Furuta, Brian B Gowen, Kimiyasu Shiraki   +2 more
exaly  

Favipiravir

Drugs of the Future, 2010
openaire   +1 more source

Favipiravir/levofloxacin

Reactions Weekly, 2022
openaire   +1 more source

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections

2020
Kimiyasu Shiraki, Tohru Daikoku
exaly  

Favipiravir

Reactions Weekly, 2016
openaire   +1 more source

Favipiravir

Reactions Weekly
openaire   +2 more sources

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

Clinical Infectious Diseases, 2017
Vanessa Raabe, Gerrit Kann, Aneesh K Mehta   +2 more
exaly  

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza

EBioMedicine, 2020
Yeming Wang, Alex P Salam, Joel Tarning   +2 more
exaly